Clinical Trial Update: Pembrolizumab in Treating Patients With Advanced Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab in advanced uveal melanoma was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Stage IIIA Uveal Melanoma, Stage IIIB Uveal Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2018-04-24